We urge you to Vote — http://abcnews.go.com/GMA/OnCall/story?id=2640591&page=1 We need a letter writing campaign to stop the mad doctors from stunting infants' development The psychiatrists among you, please raise your voice –Help! Latest Vote Tally (Sunday. 8:00AM: "Absolutely NO'–5,450; No, babies can't be depressed—612; OK if doctors says so—124. TOTAL VOTE: 6,186
Dr. E. Jane Costello, a professor of psychiatry and behavioral sciences at Duke University, acknowledges: “The system of diagnosis is still 200 to 300 years behind other branches of medicine.” Psychiatry also fails to be guided by an evidence-based positive benefit / risk assessment of its prescribed treatments.
The ethics of this radical drug experiment is being challenged by Dr. Jerald Block, a forthright psychiatrist and experienced system's analyst. His critical appraisal, published in the Bioethics Forum, Hastings Center Report.
Disease mongering: " This program has been developed for people who, while in the prime of their lives, are at high risk for developing a debilitating mental illness."
The Whistleblower: Confessions of a Healthcare Hitman by Dr. Peter Rost, published by Soft Skull Press.
Legislation is needed to ensure that conflicts of interest rules in medicine are enforced. One method for reigning in the abuse is to prohibit government grant awards to any researcher who violates financial conflict of interest rules.
The New York Times reports: "For big drug companies, the new Medicare prescription benefit is proving to be a financial windfall larger than even the most optimistic Wall Street analysts had predicted."
AHRP applauds the California chapter of the NAACP for unanimously passing a resolution to end the abusive prescribing of psychotropic drugs for children in foster care!
Off-label prescribing of drugs for unapproved uses puts consumers at high risk of harm–but it is the single most lucrative marketing strategy.
Two surveys confirm medical researchers' resistance to complying with conflict of interest disclosure requirements.
Today's news report circulated by the media about the negative findings of a much touted, but uncontrolled observational study of depression (STAR*D) promotes the business interests of SSRI antidepressant drug manufacturers.
